Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

ClinicalTrials.gov ID: NCT02460978

Public ClinicalTrials.gov record NCT02460978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 8:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus - Study Two

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if adding dapagliflozin to insulin is a safe and effective therapy to improve glycemic control in patients with type 1 diabetes.

Study identification

NCT ID
NCT02460978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
815 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 7, 2015
Primary completion
Sep 1, 2017
Completion
Apr 17, 2018
Last update posted
Mar 4, 2019

2015 – 2018

United States locations

U.S. sites
47
U.S. states
19
U.S. cities
43
Facility City State ZIP Site status
Research Site Concord California 94520
Research Site Fresno California 93720
Research Site Los Angeles California 90057
Research Site Orange California 92868
Research Site San Mateo California 94401
Research Site San Ramon California 94583
Research Site Walnut Creek California 94598
Research Site Golden Colorado 80401
Research Site Newark Delaware 19713
Research Site Bradenton Florida 34201
Research Site Clearwater Florida 33756
Research Site Fort Lauderdale Florida 33312
Research Site Jacksonville Florida 32216
Research Site Miami Florida 33156
Research Site Miami Springs Florida 33166
Research Site St. Petersburg Florida 33709
Research Site Tampa Florida 33634
Research Site Atlanta Georgia 30308
Research Site Atlanta Georgia 30318
Research Site Roswell Georgia 30076
Research Site Chicago Illinois 60607
Research Site Chicago Illinois 60611
Research Site Des Moines Iowa 50314
Research Site Overland Park Kansas 66209
Research Site Lexington Kentucky 40502
Research Site Lexington Kentucky 40503
Research Site Kalamazoo Michigan 49008
Research Site Edina Minnesota 55435
Research Site Jefferson City Missouri 65109
Research Site St Louis Missouri 63110
Research Site Reno Nevada 89511
Research Site Albuquerque New Mexico 87109
Research Site Albany New York 12208
Research Site Flushing New York 11355
Research Site Mineola New York 11501
Research Site New Hyde Park New York 11042
Research Site New York New York 10029
Research Site Philadelphia Pennsylvania 19107-4824
Research Site Amarillo Texas 79106
Research Site Austin Texas 78731
Research Site Dallas Texas 75231
Research Site Edinburg Texas 78539
Research Site Mesquite Texas 74194
Research Site San Antonio Texas 78229
Research Site San Antonio Texas 78258
Research Site Bennington Vermont 05201
Research Site Federal Way Washington 98003

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02460978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 4, 2019 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02460978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →